February 16th, 2024
Potential new weapon in battle against superbugs
Harvard researchers have created an antibiotic that can overcome many drug-resistant infections.
News All News
Press Contact: Kirsten Mabry | (617) 495-4157
Tag: Drug Development
February 23rd, 2022
Cantex licenses IP from Harvard to develop repurposed drug identified by Wyss Institute to treat inflammatory lung diseases including COVID-19
Organ Chip studies revealed azeliragon can reduce virus-associated inflammation in human lung tissue
June 2nd, 2021
Harvard licenses technology to Obatala Sciences to advance discovery in obesity, diabetes, and cancer
Development by New Orleans biotech company to enable studies of human fat tissue in vitro
June 17th, 2019
Harvard chemists’ breakthrough in synthesis advances a potent anti-cancer agent
‘Unprecedented achievement’ provides sufficient quantities of a fully synthetic halichondrin molecule for clinical trials now underway
